Comments

Vera Therapeutics Stock Guidance

VERANASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$30.29
0.361.20%
Q4 2024 Earnings were released on Wed Feb 26th, before the market open
Vera Therapeutics (VERA) ForecastNewsEarningsVera Therapeutics (VERA) Options

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Vera Therapeutics Stock Guidance | NASDAQ:VERA | Benzinga

Vera Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Vera Therapeutics (VERA)?

A

There have been no specific sales or earnings guidance reported for Vera Therapeutics in recent months.

Browse guidance and forecast on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved